Immune system proteins may worsen kidney disease in diabetes, new study investigates
NCT ID NCT07292493
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how the complement system, a part of the immune system, may contribute to kidney damage in people with diabetes. Researchers will measure complement proteins in blood and urine from 90 participants to see if they are linked to kidney disease severity and blood vessel health. The goal is to better understand the disease process, not to test a new treatment.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal new targets for treating or preventing diabetic kidney disease.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test any therapy, and results may not lead to immediate clinical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COMPLEMENT SYSTEM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Medical Centre Ljubljana
Ljubljana, 1000, Slovenia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Blood test may predict rapid kidney decline in diabetes
- Blood test could flag rapid kidney failure risk in diabetes
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Could your blood type predict kidney treatment success?
- Text messages and nurses: a new strategy to tackle hypertension in tanzania?